Literature DB >> 1982311

The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers.

H A Titulaer1, J Zuidema, P A Kager, J C Wetsteyn, C B Lugt, F W Merkus.   

Abstract

The pharmacokinetics after oral, intramuscular and rectal administration of artemisinin, a new potent antimalarial drug, to healthy volunteers has been examined. The study was set-up as a four-way cross-over design with a wash-out period of one week between the test days. In ten volunteers artemisinin concentrations in serum were monitored using a reversed phase HPLC assay with UV detection after derivatization. After oral administration, artemisinin was rapidly but incompletely absorbed, the mean absorption time was 0.78 h and the bioavailability relative to the intramuscularly injected suspension in oil 32%. The mean residence time of the latter (10.6 h) was 3 times that of the oral formulation (3.4 h). This seems to enable a twice daily dosage regimen for the intramuscular oil injection, while the oral formulation necessitates a more frequent dosing interval. After intramuscular injection and rectal administration of an aqueous suspension, very low and variable artemisinin concentrations in serum were observed, probably indicating a poor and erratic absorption.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982311     DOI: 10.1111/j.2042-7158.1990.tb07030.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  25 in total

1.  In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum.

Authors:  S Gupta; M M Thapar; W H Wernsdorfer; A Björkman
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 2.  Pharmacokinetic interactions of antimalarial agents.

Authors:  P T Giao; P J de Vries
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 3.  Safety assessment of peroxide antimalarials: clinical and chemical perspectives.

Authors:  B K Park; P M O'Neill; J L Maggs; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 4.  Oxidative stress in malaria; implications for prevention and therapy.

Authors:  N S Postma; E C Mommers; W M Eling; J Zuidema
Journal:  Pharm World Sci       Date:  1996-08

5.  Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseases.

Authors:  Pamela J Weathers; Patrick R Arsenault; Patrick S Covello; Anthony McMickle; Keat H Teoh; Darwin W Reed
Journal:  Phytochem Rev       Date:  2011-06       Impact factor: 5.374

6.  Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunate.

Authors:  W Ittarat; S Looareesuwan; P Pootrakul; P Sumpunsirikul; P Vattanavibool; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

7.  It is not just artemisinin: Artemisia sp. for treating diseases including malaria and schistosomiasis.

Authors:  B M Gruessner; L Cornet-Vernet; M R Desrosiers; P Lutgen; M J Towler; P J Weathers
Journal:  Phytochem Rev       Date:  2019-09-19       Impact factor: 5.374

8.  Antiplasmodial activity of targeted zinc(II)-dipicolylamine complexes.

Authors:  Douglas R Rice; María de Lourdes Betancourt Mendiola; Claribel Murillo-Solano; Lisa A Checkley; Michael T Ferdig; Juan C Pizarro; Bradley D Smith
Journal:  Bioorg Med Chem       Date:  2017-03-27       Impact factor: 3.641

9.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

10.  Determination of Artemisinin in Bulk and Pharmaceutical Dosage Forms using HPTLC.

Authors:  S P Agarwal; A Ali; Yashomati Dua; Shipra Ahuja
Journal:  Indian J Pharm Sci       Date:  2009-01       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.